Urtoxazumab is a humanized monoclonal antibody against diarrhoea caused by Escherichia coli serotype O121. The drug is designed to bind to a toxin of this bacterium so that it can be more easily broken down and eliminated from the body.
This page contains content from the copyrighted Wikipedia article "Urtoxazumab"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.